Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine

The Brief Psychiatric Rating Scale

1962 • 10,683 citations

Clozapine for the Treatment-Resistant Schizophrenic

1988 • 4,030 citations

A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS

1970 • 3,213 citations

A Rating Scale for Drug-Induced Akathisia

1989 • 2,135 citations

Negative v Positive Schizophrenia

1982 • 2,003 citations

Molecular pathology of schizophrenia: more than one disease process?

1980 • 1,877 citations

Radioreceptor Binding Profile of the Atypical Antipsychotic Olanzapine

1996 • 1,047 citations

Olanzapine versus Placebo and Haloperidol

1996 • 788 citations

Symptoms of Schizophrenia

1995 • 734 citations

Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia

1994 • 391 citations

Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome

1994 • 380 citations

A Longitudinal Study of Symptom Dimensions in Schizophrenia

1995 • 303 citations

A prospective study of clozapine in treatment-resistant schizophrenic patients

1989 • 269 citations

Negative and Deficit Symptoms in Schizophrenia Do Respond to Neuroleptics

1985 • 174 citations

Case identification and stability of the deficit syndrome of schizophrenia

1993 • 174 citations

Patient response and resource management: another view of clozapine treatment of schizophrenia

1995 • 166 citations

Structure and Course of Positive and Negative Symptoms in Schizophrenia

1995 • 164 citations

Statistical Models for Causal Analysis

1993 • 162 citations

A path-analytical approach to differentiate between direct and indirect drug effects on negative symptoms in schizophrenic patients

1995 • 146 citations

The Effect of Neuroleptics and Other Psychotropic Drugs on Negative Symptoms in Schizophrenia

1986 • 143 citations

A PET Study of 5-HT2 and D2 Dopamine Receptor Occupancy Induced by Olanzapine in Healthy Subjects

1997 • 132 citations

Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine — a123 IBZM single photon emission tomography (SPET) study

1996 • 124 citations

Clozapine's effect on negative symptoms in treatment-refractory schizophrenics

1994 • 112 citations

Evaluation of positive and negative symptoms in schizophrenia

1986 • 112 citations

Novel antipsychotic drugs

1993 • 100 citations

Negative symptoms in schizophrenia: a confirmatory factor analysis of competing models

1995 • 94 citations

Do Negative Symptoms Respond to Pharmacological Treatment?

1989 • 66 citations

Positive and negative symptoms covary during clozapine treatment in schizophrenia

1993 • 49 citations

Mutability and relationship between positive and negative symptoms during neuroleptic treatment in schizophrenia

1990 • 46 citations

Effect of Pimozide on Positive and Negative Symptoms in Schizophrenic Patients: Are Negative Symptoms State Dependent?

1987 • 44 citations

Predictors of response to clozapine therapy

1989 • 41 citations

Covariance of positive and negative symptoms during neuroleptic treatment in schizophrenia: A replication

1993 • 40 citations

Olanzapine, a novel atypical antipsychotic, reversesd-amphetamine-induced inhibition of midbrain dopamine cells

1996 • 31 citations

Clozapine response varies in deficit vs non-deficit schizophrenic subjects

1994 • 29 citations

Psychopharmacologic treatment of negative schizophrenic symptoms

1994 • 22 citations